In ovarian cancer, we found that GPR176 mRNA expression positively correlated with older age, clinicopathological staging and tumor residual status (Yang et al. 2023), while GPR176 expression at both mRNA and protein levels was associated with low T staging and good PAM50 classification of breast cancer (Yun et al. 2023). Here, GPR176 is linked to ovarian carcinoma.